ppjv7630
Vaccineexperimental
Clinical trial activity
1 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
0
Phase 3
0
Phase 4
0
Earliest trial started Apr 1, 2006 (NCT00310271)
Timeline
2000s
- Jan 1, 2006
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- HSV-2Immunity, active
HSV-2 immunity, active
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- ppjv7630
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00310271 | Phase 1 | Apr 1, 2006 | Pharmaceutical Research Associates, Inc. (PRA), PowderMed |
Showing 1 of 1 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pharmaceutical Research Associates, Inc. (PRA) | For profit | 1 | 0 | 1 | 2006 |
| PowderMed | For profit | 1 | 1 | 1 | 2006 |
2 organizations
Page 1 / 1